LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.52 | 84.90 | 8990 | 9214 | 0.9756 | 0.9927 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.52 | 84.90 | 8025 | 9214 | 0.8709 | 0.9595 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.52 | 84.90 | 8182 | 9214 | 0.8880 | 0.9652 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.22 | 84.90 | 761 | 9343 | 0.0814 | 0.3818 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.22 | 84.90 | 9142 | 9343 | 0.9784 | 0.9936 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.22 | 84.90 | 8175 | 9343 | 0.8749 | 0.9610 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.22 | 84.90 | 8336 | 9343 | 0.8922 | 0.9666 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.93 | 84.90 | 759 | 8970 | 0.0846 | 0.3852 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.93 | 84.90 | 9328 | 8970 | 1.0398 | 1.0117 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.93 | 84.90 | 8237 | 8970 | 0.9182 | 0.9748 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 75.93 | 84.90 | 8527 | 8970 | 0.9506 | 0.9850 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 77.64 | 84.90 | 825 | 9245 | 0.0892 | 0.3994 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 77.64 | 84.90 | 9450 | 9245 | 1.0221 | 1.0065 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 77.64 | 84.90 | 8055 | 9245 | 0.8712 | 0.9597 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 77.64 | 84.90 | 8631 | 9245 | 0.9335 | 0.9798 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 79.34 | 84.90 | 867 | 9051 | 0.0958 | 0.4119 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 79.34 | 84.90 | 9656 | 9051 | 1.0668 | 1.0193 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 79.34 | 84.90 | 8077 | 9051 | 0.8923 | 0.9665 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 79.34 | 84.90 | 8790 | 9051 | 0.9711 | 0.9913 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 81.05 | 84.90 | 937 | 8863 | 0.1057 | 0.4306 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 81.05 | 84.90 | 9841 | 8863 | 1.1102 | 1.0314 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 81.05 | 84.90 | 7518 | 8863 | 0.8482 | 0.9515 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 81.05 | 84.90 | 8825 | 8863 | 0.9956 | 0.9987 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.75 | 84.90 | 884 | 8621 | 0.1025 | 0.4212 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.75 | 84.90 | 10095 | 8621 | 1.1709 | 1.0479 | MN20160318_Q02 | F15 |